Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 2
Submit an article Journal homepage
189
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Lack of clinical benefit of zoledronic acid in myelofibrosis: results of a prospective multi-center phase II trial

Michel DelforgeDepartment of Hematology, University Hospital Leuven, Leuven, BelgiumCorrespondence[email protected]
,
Timothy DevosDepartment of Hematology, University Hospital Leuven, Leuven, Belgium
,
Jacob RoweDepartment of Hematology and Bone Marrow Transplantation, RAMBAM Medical Center and Technion, Haifa, Israel
,
Ignacio EspañolDepartment of Hematology, Santa Lucia University Hospital, Cartagena, Spain
,
Simon T. DurrantCancer Care Services, Royal Brisbane and Women's hospital, Brisbane, Australia
,
Jolien RaddouxDepartment of Hematology, University Hospital Leuven, Leuven, Belgium
,
Marc BoogaertsDepartment of Hematology, University Hospital Leuven, Leuven, Belgium
,
Martin GramatzkiSection for Stem Cell- and Immunotherapy, Medizinische Klinik, Kiel, Germany
&
Andreas GuntherSection for Stem Cell- and Immunotherapy, Medizinische Klinik, Kiel, Germany
 show all
Pages 470-473 | Received 26 Feb 2015, Accepted 20 May 2015, Published online: 07 Jul 2015

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ivan Krecak, Velka Gveric-Krecak, Pavle Roncevic, Sandra Basic-Kinda, Josipa Gulin, Ivana Lapic, Ksenija Fumic, Ivana Ilic, Ivana Horvat, Renata Zadro, Hrvoje Holik, Bozena Coha, Nena Peran, Igor Aurer & Nadira Durakovic. (2018) Serum chitotriosidase: a circulating biomarker in polycythemia vera. Hematology 23:10, pages 793-802.
Read now

Articles from other publishers (1)

Ashley P. Ng. (2019) I myelofibrosis! Veni VitD! Et tu, macrophage?. Blood 133:15, pages 1613-1615.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.